The global Viral Inactivation Market size is projected to reach USD 596.4 million by 2026, from USD 400.2 million in 2020, at a CAGR of 7.8% during 2021-2026.
Viral inactivation is to stop the viruses in a given sample from contaminating the desired product either by removing viruses completely or rendering them non-infectious. These techniques are used widely in the food and blood plasma industries, as those products can be harmed by the presence of viral particles.
Major Key players of the viral inactivation market are Danaher, Merck, Parker Hannifin, Sartorius, SGS, Charles River Laboratories International, Clean Cells, Rad Source Technologies and Texcell.
Viral epidemics develop from the emergence of new variants of infectious viruses. The lack of effective antiviral treatments for the new viral infections coupled with rapid community spread of the infection often result in major human and financial loss. Viral transmissions can occur via close human?to?human contact or via contacting a contaminated surface. Thus, careful disinfection or sanitization is essential to curtail viral spread. Cytiva is developing a specific prototype affinity resin and providing technology and services to support the efforts of those scientists which currently in pre-clinical testing, the vaccine is being prepared to enter clinical trials. Cytiva will bring manufacturing support and technology to the overall program, including supporting the making of clinical trial phase I vaccine at the Commonwealth Scientific and Industrial Research Organization (CSIRO), an Australian government scientific research group. Cytiva will also create a specific prototype affinity resin for vaccine purification at its site in Uppsala and support scale up with planning underway for phase II material manufacturing through its Fast Trak center.
Cold plasma gives new hope in viral Inactivation - Viruses can infect all cell-based organisms, from bacteria to humans, animals, and plants. They are responsible for numerous cases of hospitalization, many deaths, and widespread crop destruction, all of which result in an enormous medical, economical, and biological burden. Each of the currently used decontamination methods has important drawbacks. Cold plasma (CP) has entered this field as a novel, efficient, and clean solution for virus inactivation. We present recent developments in this promising field of CP-mediated virus inactivation, and describe the applications and mechanisms of the inactivation. This is particularly relevant because viral pandemics, such as COVID-19, highlight the need for alternative virus inactivation methods to replace, complement, or upgrade existing procedures.
A strain of SARS-CoV-2 isolated from a patient who developed COVID-19 in the cruise ship Diamond Princess in Japan in February 2020. The spread of novel coronavirus disease 2019 (COVID-19) infections worldwide has raised concerns about the prevention and control of SARS-CoV-2. Devices that rapidly inactivate viruses can reduce the chance of infection through aerosols and contact transmission
Market segmentation is based on their product type, Application and region. Based on product type it has been segmented into Kits and reagents, Systems and Services. On the basis of application it has been segmented into vaccines and therapeutics, Blood & Blood products and Cellular & gene Therapy products. On the basis of region it has been spread over North America, Europe, Asia-Pacific, South America and Middle East & Africa. The viral inactivation market is expected to grow In Asia-Pacific during the forecast period due to fast growth in pharmaceutical & biotechnology industries, rising number of new drug launches, growing government support for pharmaceuticals & strong R& D investments in the life sciences industry.
The report analyzes factors affecting viral infections market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., new opportunities, market trends and future growth. This showed that various technologies are emerged in market which gives market demand.